Just a moment, the page is loading...
Notice to Investigators involved in Pure Substance Request studies: Due to temporary supply issues, there may be a delay in the processing or shipping of pure substances at this time. We apologize for the inconvenience, and we appreciate your understanding.
♥




Economics and Health System Impact

Evidence is needed to understand the economic and health system implications of CAB + RPV LA compared to oral ART, including downstream impacts of adherence differences, healthcare resource utilization, and implications for public health outcomes.






ViiV ISR Area Of Interest Overview

Drug/Product Alignment
Cabotegravir
Long Acting-Treatment
Area of Interest/DataGap Description
Economic/Societal Value
Desirable Study Parameters
All Patient Types
Global

Version 20250909-disp



- Back to Top -
© 2026 ViiV Healthcare
Trademarks are owned by or licensed to the ViiV Healthcare group of companies